Copy Link Print Information

Gallic acid hydrate

(Synonyms: 3,4,5-Trihydroxybenzoic acid hydrate)
18 Cited Publications
Customer Review

Based on 18 publication(s) in Google Scholar

Gallic acid (3,4,5-Trihydroxybenzoic acid) hydrate is a natural polyhydroxyphenolic compound and an free radical scavenger to inhibit cyclooxygenase-2 (COX-2). Gallic acid hydrate has various activities, such as antimicrobial, antioxidant, antimicrobial, anti-inflammatory, and anticance activities.

For research use only. We do not sell to patients.

  • Purity: 98.87%
  • CAS No.: 5995-86-8
  • Formula: C7H8O6
  • Molecular Weight:188.13
  • Storage:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Gallic acid hydrate Chemical Structure
    Gallic acid hydrate Chemical Structure
  • Experimental Validation Results for Gallic acid hydrate
  • Experimental Validation Results for Gallic acid hydrate
  • Experimental Validation Results for Gallic acid hydrate
  • Experimental Validation Results for Gallic acid hydrate
  • Experimental Validation Results for Gallic acid hydrate
  • Experimental Validation Results for Gallic acid hydrate
  • Experimental Validation Results for Gallic acid hydrate
CAS No.: 5995-86-8
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Gallic acid hydrate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Gallic acid hydrate

More
Customer Validation & Images
Histological Imaging/StainingELISAWBRT-PCRIHC
  • Histological Imaging/Staining
  • ELISA
  • WB
  • RT-PCR
  • IHC
  • ELISA
  • RT-PCR

All COX Isoforms

More

All Endogenous Metabolite Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Gallic acid hydrate Chemical Structure
    Gallic acid hydrate Chemical Structure
    1/16
  • 1/16

    Gallic acid hydrate purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Jan 8;23(1):30. [Abstract]

    Customer Validation
     Hematoxylin and eosin (HE) and Sirius red staining revealed that after intervention with the ferroptosis inhibitor Fer-1 or Gallic acid (GA) (200 mg/kg/d, i.g.), the muscle fibers were more orderly arranged, and some muscle cells exhibited mild edema and a small amount of inflammatory cell infiltration.

  • 1/16

    Gallic acid hydrate purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Jan 8;23(1):30. [Abstract]

    Customer Validation
     Detection of IL-6, TNF-α, CK, LDH, Fe2+ and MDA levels significantly reduced treated with Gallic acid (GA) (200 mg/kg/d, i.g.) in skeletal muscle tissue by ELISA.

  • 1/16

    Gallic acid hydrate purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Jan 8;23(1):30. [Abstract]

    Customer Validation
     After Gallic acid (GA) (200 mg/kg/d, i.g.) intervention, both Piezo1 and COX2 were significantly decreased, and the expression of GPX4 and FTH1 was increased by Western blot.

  • 1/16

    Gallic acid hydrate purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Jan 8;23(1):30. [Abstract]

    Customer Validation
     Detection of Piezo1, GPX4, FTH1 and COX2 mRNA levels treated with Gallic acid (GA) (200 mg/kg/d, i.g.) in skeletal muscle tissue by RT-qPCR.

  • 1/16

    Gallic acid hydrate purchased from MedChemExpress. Usage Cited in: J Transl Med. 2025 Jan 8;23(1):30. [Abstract]

    Customer Validation
     Immunohistochemical detection of Piezo1 and GPX4 expression treated with Gallic acid (GA) (200 mg/kg/d, i.g.) in skeletal muscle tissue of different groups of mice.

  • 1/16

    Gallic acid hydrate purchased from MedChemExpress. Usage Cited in: Pharmaceutics. 2024 Jun 2;16(6):751. [Abstract]

    Customer Validation
     A549 cells were pre-treated with active compounds (Gallic acid, Chebulagic acid, and Chebulinic acid) (0–20 µg/mL) for 24 h. Then, the cells were exposed to CoV2-SP (100 ng/mL) for 3 h. The IL-6 (A), IL-1β (B), and IL-18 secretions (C) in the culture supernatant were examined by ELISA.

  • 1/16

    Gallic acid hydrate purchased from MedChemExpress. Usage Cited in: Pharmaceutics. 2024 Jun 2;16(6):751. [Abstract]

    Customer Validation
     Inhibitory effects of active compounds (Gallic acid, Chebulagic acid and Chebulinic acid) on the IL-6 (A), IL-1β (B), IL-18 (C), and NLRP3 gene expressions (D) in CoV2-SP-induced A549 cells. A549 cells were pre-treated with active compounds (gallic acid, chebulagic acid and chebulinic acid) (0–20 µg/mL) for 24 h. Then, the cells were exposed to CoV2-SP (100 ng/mL) for 3 h. The mRNA expressions were determined using RT-qPCR.

  • Gallic acid hydrate